Therapeutic potential of heat shock protein induction for muscular dystrophy and other muscle wasting conditions

• Published in: Philosophical transactions of the Royal Society of London. Series B. Biological sciences 2018-01, Vol.373 (1738), p.20160528-20160528
• Main Authors: Thakur, Savant S., Swiderski, Kristy, Ryall, James G., Lynch, Gordon S.
• Format: Article
• Language: English
• Subjects: Aberration; Animals; Atrophy; Cachexia; Cancer; Chaperones; Chronic obstructive pulmonary disease; Cytoskeleton; Denervation; Duchenne's muscular dystrophy; Dystrophy; Heat Shock Proteins; Heat-Shock Proteins - genetics; Heat-Shock Proteins - therapeutic use; Humans; Lung diseases; Mice; Modulators; Muscles; Muscular Dystrophy; Muscular Dystrophy, Duchenne - genetics; Muscular Dystrophy, Duchenne - therapy; Mutation; Obstructive lung disease; Part III: Intracellular versus Extracellular Heat Shock Proteins in Chronic Diseases; Proteins; Quality of life; Rats; Recovery of function; Review; Sarcopenia; Sepsis; Skeletal muscle; Skeletal Muscle Wasting; Trauma
• ISSN: 0962-8436; 1471-2970
• DOI: 10.1098/rstb.2016.0528

Duchenne muscular dystrophy is the most common and severe of the muscular dystrophies, a group of inherited myopathies caused by different genetic mutations leading to aberrant expression or complete absence of cytoskeletal proteins. Dystrophic muscles are prone to injury, and regenerate poorly after damage. Remorseless cycles of muscle fibre breakdown and incomplete repair lead to progressive and severe muscle wasting, weakness and premature death. Many other conditions are similarly characterized by muscle wasting, including sarcopenia, cancer cachexia, sepsis, denervation, burns, and chronic obstructive pulmonary disease. Muscle trauma and loss of mass and physical capacity can significantly compromise quality of life for patients. Exercise and nutritional interventions are unlikely to halt or reverse the conditions, and strategies promoting muscle anabolism have limited clinical acceptance. Heat shock proteins (HSPs) are molecular chaperones that help proteins fold back to their original conformation and restore function. Since many muscle wasting conditions have pathophysiologies where inflammation, atrophy and weakness are indicated, increasing HSP expression in skeletal muscle may have therapeutic potential. This review will provide evidence supporting HSP induction for muscular dystrophy and other muscle wasting conditions. This article is part of the theme issue ‘Heat shock proteins as modulators and therapeutic targets of chronic disease: an integrated perspective’.